Bruker (BRKR)

Nasdaq Health Care Health Care Equipment S&P MidCap 400

$61.31

+3.25 (+5.60%)

Close of Nov 06, 2026 · end-of-day data

Source: Bruker's 10-K / 10-Q XBRL data on SEC EDGAR · fetched Nov 06, 2026

Revenue, net income & free cash flow

Income statement

fiscal years · USD

Fiscal year	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$1.61B	$1.77B	$1.90B	$2.07B	$1.99B	$2.42B	$2.53B	$2.96B	$3.37B	$3.44B
Cost of revenue	$866.00M	$949.90M	$995.60M	$1.08B	$1.05B	$1.21B	$1.23B	$1.45B	$1.72B	$1.86B
Gross profit	$745.30M	$816.00M	$900.00M	$995.30M	$939.80M	$1.21B	$1.31B	$1.51B	$1.65B	$1.58B
Research & development	$147.90M	$161.60M	$173.40M	$187.70M	$198.00M	$220.80M	$235.90M	$294.80M	$376.50M	$395.20M
Selling, general & admin	$389.80M	$415.20M	$444.70M	$500.20M	$468.60M	$561.20M	$607.40M	$729.40M	$893.80M	$946.50M
Operating income	$181.80M	$219.50M	$262.40M	$300.90M	$248.30M	$413.30M	$432.70M	$436.90M	$253.10M	$68.20M
Interest expense	$13.20M	$15.40M	$12.60M	$16.00M	$14.40M	$14.30M	$16.10M	$16.40M	$47.90M	$60.30M
Pre-tax income	$177.60M	$197.80M	$244.70M	$280.40M	$225.80M	$393.60M	$413.90M	$544.20M	$206.90M	$22.00M
Income tax	$23.10M	$117.50M	$63.70M	$82.40M	$64.40M	$113.00M	$116.40M	$117.70M	$91.40M	$29.30M
Net income	$153.60M	$78.60M	$179.70M	$197.20M	$157.80M	$277.10M	$296.60M	$427.20M	$113.10M	-$8.60M
EBITDA	$236.10M	$283.40M	$327.30M	$376.50M	$328.70M	$502.40M	$521.50M	$551.80M	$436.90M	$288.50M
EPS (basic)	$0.95	$0.50	$1.15	$1.27	$1.03	$1.83	$2.00	$2.92	$0.76	$-0.15
EPS (diluted)	$0.95	$0.49	$1.14	$1.26	$1.02	$1.81	$1.99	$2.90	$0.76	$-0.15
Diluted shares	162.20M	159.10M	157.20M	157	155	153	149	147.20M	149.50M	151.80M
Gross margin	46.3%	46.2%	47.5%	48.0%	47.3%	50.0%	51.6%	51.0%	49.0%	45.9%
Operating margin	11.3%	12.4%	13.8%	14.5%	12.5%	17.1%	17.1%	14.7%	7.5%	2.0%
Net margin	9.5%	4.5%	9.5%	9.5%	7.9%	11.5%	11.7%	14.4%	3.4%	-0.3%

Balance sheet

fiscal years · USD

Fiscal year	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash & equivalents	$342.40M	$325.00M	$322.40M	$678.30M	$681.80M	$1.07B	$645.50M	$488.30M	$183.40M	$298.80M
Short-term investments	—	$114.20M	$0	$6.60M	$50.00M	$100.00M	$0	—	—	—
Receivables	$243.90M	$319.30M	$357.20M	$362.20M	$335.30M	$416.90M	$472.70M	$492.00M	$565.50M	$544.90M
Inventory	$440.40M	$486.20M	$509.60M	$577.20M	$692.30M	$710.10M	$800.10M	$968.30M	$1.07B	$1.09B
Total current assets	$1.28B	$1.36B	$1.30B	$1.80B	$1.93B	$2.47B	$2.11B	$2.16B	$2.05B	$2.21B
Goodwill	$130.60M	$169.80M	$275.70M	$293.00M	$320.40M	$339.50M	$457.60M	$582.60M	$1.51B	$1.55B
Total assets	$1.81B	$1.95B	$2.13B	$2.77B	$3.05B	$3.65B	$3.61B	$4.25B	$5.81B	$6.24B
Total current liabilities	$524.70M	$524.50M	$599.30M	$645.60M	$791.90M	$938.50M	$914.30M	$1.20B	$1.28B	$1.28B
Short-term debt	$20.10M	—	$18.50M	$500.00K	$2.20M	$112.40M	$18.70M	$121.20M	$32.50M	$16.60M
Long-term debt	$391.60M	$415.60M	$322.60M	$812.80M	$842.30M	$1.22B	$1.20B	$1.16B	$2.06B	$1.85B
Total debt	$411.70M	$415.60M	$341.10M	$813.30M	$844.50M	$1.33B	$1.22B	$1.28B	$2.09B	$1.87B
Total liabilities	$1.12B	$1.22B	$1.23B	$1.86B	$2.09B	$2.58B	$2.48B	$2.84B	$3.99B	$3.73B
Shareholders' equity	$686.40M	$725.40M	$896.60M	$906.80M	$961.20M	$1.07B	$1.11B	$1.38B	$1.78B	$2.46B

Cash flow

fiscal years · USD

Fiscal year	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Operating cash flow	$130.80M	$154.40M	$239.70M	$213.40M	$332.20M	$282.40M	$274.40M	$350.10M	$251.30M	$134.10M
Capital expenditures	$37.10M	$43.70M	$49.20M	$73.00M	$97.20M	$92.00M	$129.20M	$106.90M	$115.30M	$90.80M
Free cash flow	$93.70M	$110.70M	$190.50M	$140.40M	$235.00M	$190.40M	$145.20M	$243.20M	$136.00M	$43.30M
Investing cash flow	-$21.80M	-$30.20M	-$123.40M	-$158.40M	-$192.70M	-$192.40M	-$251.60M	-$326.00M	-$1.76B	-$196.50M
Financing cash flow	-$27.90M	-$159.00M	-$112.40M	$300.00M	-$161.60M	$318.70M	-$415.30M	-$193.40M	$1.23B	$135.10M
Dividends paid	$25.80M	$25.40M	$25.10M	$25.00M	$24.60M	$24.20M	$29.80M	$29.40M	$30.20M	$22.80M
Share buybacks	$160.00M	$152.20M	—	$142.30M	$123.20M	$153.30M	$263.10M	$152.30M	$0	$10.00M
Stock-based compensation	$9.40M	$11.00M	$11.30M	$9.60M	$16.00M	$17.20M	$27.70M	$30.90M	$25.30M	$20.20M
Depreciation & amortization	$54.30M	$63.90M	$64.90M	$75.60M	$80.40M	$89.10M	$88.80M	$114.90M	$183.80M	$220.30M

Income statement

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Revenue	$854.50M	$721.70M	$800.70M	$864.40M	$979.60M	$801.40M	$797.40M	$860.50M	$977.20M	$823.40M	$838.50M	$874.00M
Cost of revenue	$424.20M	$368.90M	$416.10M	$445.60M	$486.30M	$410.20M	$439.50M	$481.10M	$528.00M	$443.60M	$422.50M	$444.70M
Gross profit	$430.30M	$352.80M	$384.60M	$418.80M	$493.30M	$391.20M	$357.90M	$379.40M	$449.20M	$379.80M	$416.00M	$429.30M
Research & development	$83.50M	$81.80M	$92.20M	$98.10M	$104.40M	$97.10M	$100.20M	$98.30M	$99.60M	$101.30M	$94.30M	$92.00M
Selling, general & admin	$211.20M	$195.30M	$221.30M	$229.90M	$247.30M	$225.40M	$231.40M	$242.50M	$247.20M	$242.10M	$238.90M	$226.50M
Operating income	$103.50M	$64.80M	$48.10M	$68.10M	$72.10M	$31.80M	$11.90M	-$51.80M	$76.30M	$10.20M	-$65.30M	-$91.00M
Interest expense	$4.40M	$5.00M	$15.70M	$11.60M	$15.60M	$13.10M	$15.70M	$20.30M	$11.20M	$12.20M	$17.80M	$15.40M
Pre-tax income	$240.90M	$71.60M	$23.90M	$55.30M	$56.10M	$25.10M	$500.00K	-$71.80M	$68.20M	$21.90M	-$40.70M	-$120.30M
Income tax	$37.10M	$19.80M	$16.10M	$14.80M	$40.70M	$8.70M	-$3.10M	-$14.10M	$37.80M	$2.50M	$14.20M	-$12.20M
Net income	$205.50M	$50.90M	$7.60M	$40.90M	$13.70M	$17.40M	$7.60M	-$59.60M	$26.00M	$14.40M	-$52.00M	-$111.80M
EBITDA	$140.80M	$99.50M	$93.20M	$119.10M	$125.00M	$82.20M	$68.00M	$3.90M	$134.40M	$68.50M	-$7.30M	-$36.90M
EPS (basic)	$1.41	$0.35	$0.05	$0.27	$0.09	$0.11	$0.05	$-0.41	$0.10	$0.02	$-0.41	$-0.81
EPS (diluted)	$1.40	$0.35	$0.05	$0.27	$0.09	$0.11	$0.05	$-0.41	$0.10	$0.02	$-0.41	$-0.81
Diluted shares	147.20M	146	148.00M	152.00M	800.00K	151.90M	151.70M	151.80M	100.00K	152.70M	152.30M	152.50M
Gross margin	50.4%	48.9%	48.0%	48.4%	50.4%	48.8%	44.9%	44.1%	46.0%	46.1%	49.6%	49.1%
Operating margin	12.1%	9.0%	6.0%	7.9%	7.4%	4.0%	1.5%	-6.0%	7.8%	1.2%	-7.8%	-10.4%
Net margin	24.0%	7.1%	0.9%	4.7%	1.4%	2.2%	1.0%	-6.9%	2.7%	1.7%	-6.2%	-12.8%

Balance sheet

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Cash & equivalents	$488.30M	$340.10M	$169.70M	$148.10M	$183.40M	$184.20M	$92.00M	$293.10M	$298.80M	$133.40M	$184.90M	$119.70M
Receivables	$492.00M	$475.40M	$507.20M	$538.40M	$565.50M	$537.80M	$522.60M	$550.90M	$544.90M	$542.70M	$545.90M	$563.90M
Inventory	$968.30M	$1.06B	$1.18B	$1.22B	$1.07B	$1.12B	$1.22B	$1.20B	$1.09B	$1.12B	$1.12B	$1.10B
Total current assets	$2.16B	$2.14B	$2.15B	$2.19B	$2.05B	$2.11B	$2.16B	$2.35B	$2.21B	$2.10B	$2.23B	$2.16B
Goodwill	$582.60M	$751.90M	$1.44B	$1.47B	$1.51B	$1.53B	$1.65B	$1.55B	$1.55B	$1.57B	$1.43B	$1.29B
Total assets	$4.25B	$4.51B	$5.90B	$6.11B	$5.81B	$5.93B	$6.34B	$6.43B	$6.24B	$6.13B	$6.05B	$5.83B
Total current liabilities	$1.20B	$1.18B	$1.30B	$1.32B	$1.28B	$1.34B	$1.35B	$1.27B	$1.28B	$1.36B	$1.20B	$1.17B
Short-term debt	$121.20M	$21.20M	$26.40M	$32.80M	$32.50M	$37.70M	$55.70M	$24.30M	$16.60M	$8.40M	$10.10M	$10.40M
Long-term debt	$1.16B	$1.36B	$2.13B	$2.26B	$2.06B	$2.08B	$2.38B	$1.98B	$1.85B	$1.66B	$1.81B	$1.70B
Total debt	$1.28B	$1.38B	$2.16B	$2.30B	$2.09B	$2.11B	$2.44B	$2.01B	$1.87B	$1.67B	$1.82B	$1.71B
Total liabilities	$2.84B	$3.06B	$4.08B	$4.27B	$3.99B	$4.10B	$4.52B	$4.00B	$3.73B	$3.66B	$3.65B	$3.52B
Shareholders' equity	$1.38B	$1.42B	$1.79B	$1.81B	$1.78B	$1.83B	$1.82B	$2.43B	$2.46B	$2.47B	$2.40B	$2.31B

Cash flow

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Operating cash flow	$205.50M	$21.80M	$1.10M	$38.40M	$190.00M	$65.00M	-$127.50M	-$33.20M	$229.80M	$71.20M	-$77.40M	$118.20M
Capital expenditures	$31.50M	$21.40M	$24.60M	$32.60M	$36.70M	$26.00M	$21.30M	$20.90M	$22.60M	$24.20M	$28.80M	$21.50M
Free cash flow	$174.00M	$400.00K	-$23.50M	$5.80M	$153.30M	$39.00M	-$148.80M	-$54.10M	$207.20M	$47.00M	-$106.20M	$96.70M
Investing cash flow	-$36.80M	-$304.20M	-$1.32B	-$67.60M	-$60.60M	-$26.10M	-$91.10M	-$23.80M	-$55.50M	-$39.70M	-$25.30M	-$72.70M
Financing cash flow	-$59.90M	$151.70M	$1.16B	-$2.70M	-$75.00M	-$51.20M	$95.50M	$258.40M	-$167.60M	-$204.90M	$149.20M	-$110.10M
Dividends paid	$7.30M	$7.30M	$7.70M	$7.60M	$7.60M	$7.70M	$7.60M	$0	$7.50M	$7.60M	$7.50M	$7.70M
Share buybacks	$50.40M	$0	$0	$0	$0	$10.00M	$0	$0	$0	$0	—	—
Stock-based compensation	$13.10M	$5.30M	$6.90M	$6.30M	$6.80M	$5.60M	$5.70M	$6.00M	$6.30M	$6.00M	$5.60M	$6.10M
Depreciation & amortization	$37.30M	$34.70M	$45.10M	$51.00M	$52.90M	$50.40M	$56.10M	$55.70M	$58.10M	$58.30M	$58.00M	$54.10M

Quarterly figures are rebuilt from the year-to-date totals companies report — Q4 is the full year minus the first nine months, since no 10-Q is filed for it. Values are as filed; later restatements replace earlier ones. Fiscal years are labelled by the calendar year in which they end.